The use of microbubbles in conjunction with medical ultrasound imaging is not new. However, at the moment in clinical practice, microbubbles are only used as contrast agents for example to highlight blood in the ultrasound images - an application that relies on the fact that microbubbles reflect ultrasound much better than blood or soft tissue.
The drug delivery technology being developed by scientists at Philips Research continues to utilize the contrast-enhancing capabilities of microbubbles to help ultrasound operators to locate tumors - based on their density and the fact that tumors typically grow a recognizable network of small blood vessels around themselves. What's new is that it then shatters the shells of the microbubbles in these blood vessels using a focused high-energy ultrasound pulse. As a result, the drugs contained in the microbubbles are released directly inside the tumor.
Philips is working with several academic partners, including the University of Virginia (USA) and the University of Muenster (Germany), to refine the technology. Clinical institutions, such as The Methodist Hospital in Houston (USA), are also actively researching this new and exciting field of ultrasound mediated drug delivery.
"More and more, patients are demanding treatment options that allow them to maintain their quality of life during the treatment regime, without sacrificing treatment efficacy," comments King Li, MD, Chair of the Department of Radiology at the Methodist Hospital in Houston (USA) and Professor of Radiology, Weill Cornell Medical College (USA). "The non-invasive nature of ultrasound mediated delivery is a step in this direction. Work at our and other institutions using ultrasound for drug delivery and treatment guidance has shown the potential of this technology in pre-clinical studies."
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving peopleâs lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 133,000 employees in more than 60 countries worldwide. With sales of EUR 27 billion in 2007, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.